orserdu
stemline therapeutics b.v. - elacestrant - neoplazmy prsníkov - endokrinná terapia - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
fareston
orion corporation - toremifén - neoplazmy prsníkov - endokrinná terapia - liečba prvej línie hormonálne závislej metastatickej rakoviny prsníka u postmenopauzálnych pacientov. fareston sa neodporúča pre pacientov s estrogén receptor negatívne nádorov.
faslodex
astrazeneca ab - fulvestrant - neoplazmy prsníkov - endokrinné terapia, anti-estrogény - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy. , , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. v pre - alebo perimenopauzálnych žien, kombinácia liečby s palbociclib by mali byť kombinované s luteinizačného hormónu uvoľňujúci hormón (lhrh) agonist.
fulvestrant mylan
mylan pharmaceuticals limited - fulvestrant - neoplazmy prsníkov - endokrinná terapia - fulvestrant je indikovaný na liečbu estrogén receptor pozitívne, lokálne pokročilého alebo metastatického karcinómu prsníka u žien po menopauze:predtým neboli liečení žliaz s vnútornou sekréciou, terapia, orwith relapsu ochorenia alebo po adjuvantnej anti-liečbu estrogénmi, alebo progresii ochorenia na antiestrogen terapia.
tamoxifen sandoz 10 mg
sandoz pharmaceuticals d.d., slovinsko - tamoxifén - 44 - cytostatica
tamoxifen sandoz 20 mg
sandoz pharmaceuticals d.d., slovinsko - tamoxifén - 44 - cytostatica
zitazonium 20 mg
egis pharmaceuticals plc, maďarsko - tamoxifén - 44 - cytostatica
zitazonium 10 mg
egis pharmaceuticals plc, maďarsko - tamoxifén - 44 - cytostatica
fulvestrant stada 250 mg
stada arzneimittel ag, nemecko - fulvestrant - 34 - antihormona
fulvestrant sandoz 250 mg
sandoz pharmaceuticals d.d., slovinsko - fulvestrant - 34 - antihormona